SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as the community eagerly anticipates potential European Commission approval for its ANKTIVA cancer immunotherapy, alongside significant developments from the USA-Saudi Biotech Alliance that could broaden its global reach for multiple cancer indications and ignite a substantial short squeeze.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as the community eagerly anticipates topline results from its Phase 3 superiority trial of Axpaxli for wet AMD, which the company announced will be released Tuesday. Sentiment is overwhelmingly bullish that the early data release and plans for presentation at a major retina conference signal strong positive outcomes, alongside persistent rumors of a sweetened takeover bid from Sanofi.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Infleqtion Inc. - Ordinary Shares - Class A

Churchill Capital Corp X 

Infleqtion (formerly CCCX) is garnering immense investor excitement ahead of its NYSE debut under the ticker INFQ, driven by a highly successful merger with minimal redemptions, a landmark NASA contract, and community sentiment touting its undervalued position as a leader in quantum technology.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM Integrated Shipping Services is trending as Hapag-Lloyd confirmed a signed agreement to acquire the company for $35 per share, representing a significant premium, following ZIM's board rejecting a lower management-led bid and entertaining multiple strategic offers. The community is actively debating the deal's finality, potential for a short squeeze, and the possibility of continued dividends or even a higher offer given geopolitical complexities and ZIM's perceived undervaluation.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is drawing intense investor attention ahead of upcoming Phase 3 clinical data for its COMP360 psilocybin therapy in treatment-resistant depression, with the community widely anticipating the critical MADRS score to determine the stock's immediate future. This pivotal readout is seen as a major catalyst for the company and the nascent psychedelic therapeutics sector, positioning CMPS as a potential first-mover in a field many believe is on the cusp of significant regulatory and commercial breakthroughs.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Bitcoin (BTC) is trending amid sharp price declines below critical support levels, sparking intense debate among retail traders about its immediate future and prompting fears of a deeper crash. However, this volatility is viewed by some institutional investors as a "flush out" and a buying opportunity, especially as new legislative initiatives, such as Truth Social's ETF filing and the CLARITY Act, suggest increasing mainstream integration.

Corsair Gaming, Inc. designs and supplies hardware components for personal computers. It operates through the Gamer and Creator Peripherals, and Gaming Components and Systems segments. The Gamer and Creator Peripherals segment offers gaming keyboards, mice, headsets, controllers, and gaming gear including capture cards, Stream Decks, USB microphones, studio accessories, and EpocCam software, as well as coaching and training services. The Gaming Components and Systems segment focuses on creating power supply units, or PSUs, cooling solutions, computer cases, DRAM modules, prebuilt, and custom-built gaming PCs. The company was founded by Andrew J. Paul in 1994 and is headquartered in Milpitas, CA.

Corsair Gaming Inc

Corsair Gaming is experiencing a significant surge following its strong Q4 earnings report and the announcement of a $50 million share repurchase program. The community is actively discussing its perceived undervaluation, high short interest, and potential to capitalize on AI-driven hardware demand, leading to widespread speculation of a short squeeze.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the following segments: Advanced Technology Solutions (ATS), and Connectivity and Cloud Solutions (CCS). The Advanced Technology Solutions (ATS) segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The Connectivity and Cloud Solutions (CCS) segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is trending following a strong Q4 earnings beat and significantly raised 2026 guidance, fueled by robust AI data center demand. Despite this positive news, the stock experienced a notable dip, sparking community debate about market overreaction and driving "buy the dip" sentiment.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik is trending following its announcement of preliminary Q4 results that exceeded all guided metrics, fueling optimism about its strong subscription revenue growth and critical position in AI-driven data security. The community is actively debating its valuation and competitive moat amid broader software sector volatility, with many calling it a compelling buy despite recent market pressures.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

Aircoin is drawing strong community attention and trending on the Solana ecosystem due to its unique "Airlock" mechanism, which has led to over 40% of its supply being locked by holders, fostering bullish sentiment around its transparency and community control.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration

Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration PR Newswire VANCOUVER...

Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates

Lineage Cell (LCTX) delivered earnings and revenue surprises of -550.00% and +40.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength?

Wave Life Sciences (WVE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates

Lineage Cell (LCTX) delivered earnings and revenue surprises of +50.00% and +75.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates

Nuvation Bio (NUVB) delivered earnings and revenue surprises of 0.00% and +93.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Brookdale Senior Living (BKD) Reports Q2 Loss, Misses Revenue Estimates

Brookdale (BKD) delivered earnings and revenue surprises of -28.57% and -0.64%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates

Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates

U.S. stocks were on the backfoot on Wednesday as the all-important earnings from Nvidia Corp. (<a class="mention" data-mention="$NVDA" data-symbol-id="NVDA" href="https://stocktwits.com/symbol/NVDA" target="_blank">$NVDA</a>) looms large. Given hyped up expectations, the artificial intelligence stalwart has to issue not merely strong guidance but "insane" guidance that's not yet priced in, said LPLFinancial Chief Global Strategist Quincy Krosby.Ahead of the Nvidia's earnings due after the market close, the following stocks are eliciting most bearish sentiment from the retail crowd:Williams-Sonoma, Inc. (<a class="mention" data-mention="$WSM" data-symbol-id="WSM" href="https://stocktwits.com/symbol/WSM" target="_blank">$WSM</a>)Shares of San Francisco, California-based omni-channel specialty retailer of home products, soared to a record high following a beat-and-raise quarter.&nbsp;Retail largely ignored the positive results and the stock strength and fretted over valuation.&nbsp;<stembedurl>https://stocktwits.com/FetchDog/message/593355051</stembedurl>XP, Inc. (<a class="mention" data-mention="$XP" data-symbol-id="XP" href="https://stocktwits.com/symbol/XP" target="_blank">$XP</a>)&nbsp;XP shares fell over 5% after the Brazilian financial services company reported a double miss for the third quarter. Traders largely ignored a new share repurchase agreement announced by the company.Lineage Cell Therapeutics, Inc. (<a class="mention" data-mention="$LCTX" data-symbol-id="LCTX" href="https://stocktwits.com/symbol/LCTX" target="_blank">$LCTX</a>)Micro-cap clinical-stage biopharma Lineage Cell Therapeutics announced that it entered into definitive agreements with certain healthcare focused institutional investors and with Broadwood Partners, L.P. for raising up to $66 million in a registered direct offering of common stocks and warrants to purchase common stock. The stock was down over 30% at last check.Star Bulk Carriers Corp. (<a class="mention" data-mention="$SBLK" data-symbol-id="SBLK" href="https://stocktwits.com/symbol/SBLK" target="_blank">$SBLK</a>)Greek shipping company Star Bulk Carriers has seen its stock fall over 4.5% as traders digested its mixed earnings report released Tuesday after the close. Incidentally, peer ZIM Integrated Shipping Services Ltd. (<a class="mention" data-mention="$ZIM" data-symbol-id="ZIM" href="https://stocktwits.com/symbol/ZIM" target="_blank">$ZIM</a>) reported a double beat.&nbsp;e.l.f. Beauty, Inc. (<a class="mention" data-mention="$ELF" data-symbol-id="ELF" href="https://stocktwits.com/symbol/ELF" target="_blank">$ELF</a>)Shares of Oakland, California-based e.l.f. Beauty, a maker of cosmetics and skincare products, shed over 9% after short-seller Carson Block's Muddy Waters Research said it is short on the stock.&nbsp;"We believe it's overstating revenue, profits, inventory," the firm <a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/muddywatersre/status/1859273379145978200">said</a> in a post on X, adding that about 80% of its products are imported. Import data showed that the company's imports crashes by two-thirds, three quarters ago and haven't recovered since then, it added.The firm sees revenue overstatement to the tune of $135 million-$190 million.For updates and corrections email <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>&nbsp;Read Next:<a href="https://stocktwits.com/news-articles/markets/equity/these-5-stocks-elicited-most-bullish-reactions-from-retail-mid-day-wednesday-novemeber-20/cJ46o5JRXJ"> 5 Stocks Retail Investors Are Most Bullish On At Mid-Day&nbsp;</a>

S&P 500 Index trades listlessly ahead of Nvidia earnings. 

5 Stocks Retail Investors Are Most Bearish On At Mid-Day

Disappointing retail earnings and concerns about bloated valuations are weighing down on retail sentiment toward some stocks.

Equity

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. The company's cell and drug delivery programs are based upon its proprietary HyStem cell and drug delivery matrix technology. It engages in the research and development of regenerative medicine or therapeutic products for advancement in the field of oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer and hydrogel products that may be used in surgery and products for human embryonic stem cell research. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Carlsbad, CA.

Lineage Cell Therapeutics Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

LCTX
Lineage Cell Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest LCTX News

LCTXLineage Cell Therapeutics Inc